Surgical Site Infection Control Market Report by Product (Antibiotic Prophylaxis Products, Wound Care Dressings, Surgical Drapes, Surgical Clippers, Antiseptics and Disinfectants, Wound Irrigation Products, and Others), Infection Type (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI), Surgery Type (Cesarean Section, Gastric Bypass, Cataract Surgery, Dental Restoration, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
The global surgical site infection control market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.78% during 2024-2032.
Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 4.6 Billion
Market Forecast in 2032
US$ 6.5 Billion
Market Growth Rate 2024-2032
3.78%
Surgical site infection (SSI) control refers to various practices or measures employed to prevent infections among patients during their stay at the hospital. These infections occur after surgery in the operated part of the body, leading to poor wound healing and extended overnight stays for the treatment. SSI control is essential as these infections can be severe and affect tissues, organs, or implants. Some commonly used SSI control products include surgical drapes, gloves, hair covers, disinfectants, skin preparation solutions, scrubs, and medical nonwovens. In recent years, SSI control solutions have gained traction across the healthcare sector as they help prevent infections, enhance patient care quality, and improve surgical outcomes and success rates.
Surgical Site Infection Control Market Trends:
SSI control products assist in reducing the duration of hospital stays, eliminating the need for revision surgeries, and minimizing patient discomfort. As a result, the rising cases of hospital-acquired infections represent the primary factor driving the market growth. Besides this, the growing awareness regarding SSIs and the shifting focus toward infection prevention through proper control measures are augmenting the product demand. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, gastrointestinal disorders, and cardiovascular diseases (CVDs), due to the aging population, sedentary lifestyles, and unhealthy eating habits. This, in confluence with the increasing number of patients undergoing surgical procedures, is accelerating the adoption of SSI control products. Furthermore, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are catalyzing the market growth. Moreover, the rising integration of SSI control products with advanced technologies, improving healthcare infrastructure, and ongoing research and development (R&D) activities are some of the factors creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical site infection controlmarket report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, infection type, surgery type and end user.
Breakup by Product:
Antibiotic Prophylaxis Products
Wound Care Dressings
Surgical Drapes
Surgical Clippers
Antiseptics and Disinfectants
Wound Irrigation Products
Others
Breakup by Infection Type:
Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI
Breakup by Surgery Type:
Cesarean Section
Gastric Bypass
Cataract Surgery
Dental Restoration
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation, etc.
Report Coverage:
Report Features
Details
Base Year of the Analysis
2023
Historical Period
2018-2023
Forecast Period
2024-2032
Units
US$ Billion
Segment Coverage
Product, Infection Type, Surgery Type, End User, Region
Region Covered
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered
3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global surgical site infection control market was valued at US$ 4.6 Billion in 2023.
We expect the global surgical site infection control market to exhibit a CAGR of 3.78% during 2024-2032.
The rising cases of hospital-acquired infections, along with the increasing demand for surgical site infection control products, as they aid in reducing hospital stays, minimizing patient discomfort, and eliminating the need for revision surgeries, are primarily driving the global surgical site infection control market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for surgical site infection control.
Based on the product, the global surgical site infection control market has been divided into antibiotic prophylaxis products, wound care dressings, surgical drapes, surgical clippers, antiseptics and disinfectants, wound irrigation products, and others. Among these, antibiotic prophylaxis products currently exhibit a clear dominance in the market.
Based on the infection type, the global surgical site infection control market can be categorized into superficial incisional SSI, deep incisional SSI, and organ or space SSI. Currently, superficial incisional SSI accounts for the majority of the global market share.
Based on the surgery type, the global surgical site infection control market has been segregated into cesarean section, gastric bypass, cataract surgery, dental restoration, and others, where cesarean section currently holds the largest market share.
Based on the end user, the global surgical site infection control market can be bifurcated into hospitals, ambulatory surgical centers, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global surgical site infection control market include 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation, etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.